You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)

Article metrics

Article menu

Download PDFPDF

Immune cell therapies and immune cell engineering
Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)

 

Online download statistics by month:

Online download statistics by month: January 2022 to January 2026

AbstractFullPdf
Jan 2022978993308
Feb 2022366367155
Mar 2022346364111
Apr 202227628480
May 2022277281102
Jun 202231132388
Jul 202227628459
Aug 202229230395
Sep 202229930498
Oct 2022355365101
Nov 2022369372124
Dec 202225125167
Jan 202329429576
Feb 202333233484
Mar 202331932093
Apr 202327727897
May 202330030264
Jun 202320921154
Jul 202315715872
Aug 202321621857
Sep 202318518666
Oct 202318318341
Nov 202321922062
Dec 202325926381
Jan 202415615685
Feb 202415215474
Mar 2024227230153
Apr 2024208209141
May 202416817091
Jun 202416016590
Jul 202417517688
Aug 202411912555
Sep 202416216172
Oct 202418018179
Nov 202417417584
Dec 2024210211107
Jan 202519719882
Feb 2025181181119
Mar 2025198218105
Apr 2025225225107
May 2025182187125
Jun 202514014070
Jul 2025110
Sep 2025550
Jan 2026001
Total10566107273963